1. Home
  2. BCPC vs WGS Comparison

BCPC vs WGS Comparison

Compare BCPC & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Balchem Corporation

BCPC

Balchem Corporation

HOLD

Current Price

$160.28

Market Cap

4.8B

Sector

Industrials

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$136.29

Market Cap

4.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCPC
WGS
Founded
1967
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Retail: Computer Software & Peripheral Equipment
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BCPC
WGS
Price
$160.28
$136.29
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$176.00
$138.13
AVG Volume (30 Days)
211.9K
382.0K
Earning Date
02-20-2026
02-17-2026
Dividend Yield
0.60%
N/A
EPS Growth
22.48
N/A
EPS
4.57
0.07
Revenue
$1,013,548,000.00
$402,190,000.00
Revenue This Year
$10.41
$41.17
Revenue Next Year
$5.89
$23.53
P/E Ratio
$35.15
$1,869.35
Revenue Growth
7.55
50.50
52 Week Low
$139.17
$55.17
52 Week High
$177.40
$170.87

Technical Indicators

Market Signals
Indicator
BCPC
WGS
Relative Strength Index (RSI) 60.13 46.39
Support Level $153.44 $124.26
Resistance Level $157.77 $138.73
Average True Range (ATR) 3.13 5.87
MACD 0.06 -0.15
Stochastic Oscillator 83.93 63.97

Price Performance

Historical Comparison
BCPC
WGS

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: